AI Clinical Decision Support Is Everywhere. The Evidence Base Is Not.
71% of US hospitals now deploy predictive AI, but validation frameworks lag dangerously behind. Here's what that gap means...
71% of US hospitals now deploy predictive AI, but validation frameworks lag dangerously behind. Here's what that gap means...
ICON's multi-year Claude deployment will reshape eTMF workflows, protocol timelines, and site data ops. Here's what coordinators need to...
Nature Medicine's clinically validated AI chatbot audit framework arrives as FDA still lacks generative AI mental health approval standards—here's...
ICON's Anthropic partnership deploys Claude into clinical trial monitoring. Here's what site coordinators and ops leads need to verify...
ICON's Anthropic partnership deploys Claude AI into clinical trials. Here's what it means for EDC workflows, IRB docs, and...
Nature Medicine finds neuroimaging AI trained on routine health system data beats curated trial datasets. FDA's RWE framework for...
FDA and EMA published coordinated AI frameworks in 2025-2026, but sponsor comment letters reveal the real debate: do these...
A multicenter RCT in Nature Medicine just validated AI-based IRD diagnosis—and exposed a gaping hole in how the FDA...
Harvard's COMPASS AI predicts checkpoint inhibitor response across 33 cancer types with 8.5% better accuracy—but translating that into trial...
Health AI acing benchmarks while failing real clinical tasks exposes a validation gap that trial sponsors and the FDA...